Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30

Journal of Dispersion Science and Technology

Volumn 29, Issue 2, 2008, Pages 193-204

  Patel, Rakesh ^a   Patel, Madhabhai ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

Dissolution; Simvastatin; Solid dispersion; Solubility

Indexed keywords

CHARACTERIZATION; DISSOLUTION; DRUG PRODUCTS; POLYETHYLENE GLYCOLS; POLYMER MATRIX; SOLUBILITY; VINYL RESINS; WETTING;

DISSOLUTION RATE; POLYVINYLPYRROLIDONE; SOLID DISPERSION;

DISPERSIONS;

CHARACTERIZATION; DISPERSIONS; DISSOLUTION; DRUG PRODUCTS; POLYETHYLENE GLYCOLS; POLYMER MATRIX; SOLUBILITY; VINYL RESINS; WETTING;

EID: 39049128727     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932690701706946     Document Type: Article

References (47)

1. Habib, F. S. and Attia, M. A. (1985) Drug Dev. Ind. Pharm., 11, pp. 2009-2019.
2. Chow, A. H. -L., Hsia, C. K., Gordon, J. D., Young, J. W. M. and Vargha-Butler, E. I. (1995) Int. J. Pharm., 126, pp. 21-28.
3. Flego, C., Lovrecich, M. and Rubessa, F. (1998) Drug Dev. Ind. Pharm., 14, pp. 1185-1202.
4. Craig, D. Q. M. and Newton, J. M. (1992) Int. J. Pharm., 78, pp. 175-182.
5. Yamaguchi, T., Nishimura, M., Okamoto, R., Takeuchi, T. and Yamamoto, K. (1992) Int. J. Pharm., 85, pp. 87-96.
6. Pitha, J. (1985) J. Pharm. Sci., 74, pp. 987-990.
7. Sekiguchi, K., Kanke, M., Tsuda, Y., Ishida, K. and Tsuda, T. (1973) Chem. Pharm. Bull., 21, pp. 1592-1600.
8. Chiou, W. L. and Riegelman, S. (1971) J. Pharm. Sci., 60, pp. 1281-1302.
9. Ford, J. L. (1986) Pharm. Acta Heh., 61, pp. 69-88.
10. Hajratwala, B. R. (1974) Aust. J. Pharm. Sci., pp. 101-109.
11. Puisieux, F. and Henry, S. (1981) Labo Pharm. Prob. Techn., 305, pp. 11-20.
12. Vila-Jato, J. L. and Alonso, M. J. (1986) Drug Dev. Ind. Pharm., 12, pp. 701-711.
13. Law, S. L. and Chiang, C. H. (1990) Drug Dev. Ind. Pharm., 16, pp. 137-147.
14. Fernandez, M., Rodriguez, I. C., Margarit, M. V. and Cerezo, A. (1992) Int. J. Pharm., 84, pp. 197-202.
15. Jachowicz, R., Nurenberg, E. and Hoppe, R. (1993) Int. J. Pharm., 99, pp. 321-325.
16. Sheu, M. T., Yeh, C. M. and Sokoloski, T. D. (1994) Int. J. Pharm., 103, pp. 137-146.
17. Craig, D. Q. M. (2002) Int. J. Pharm., 231, pp. 131-144.
18. Taylor, L. S. and Zografi, G. (1997) Pharm. Res., 14, pp. 1691-1698.
19. Arias, M. J., Gines, J. M., Moyano, J. R., Perez-Martinez, J. I. and Rabasco, A. M. (1995) Int. J. Pharm., 123, pp. 25-31.
20. Kai, T., Akiyama, Y., Nomura, S. and Sato, M. (1996) Chem. Pharm. Bull., 44, pp. 568-571.
21. Nyström, C. and Sjökvist, E. (1996) European Symposium Formulation of Poorly-available Drugs for Oral Administration, Minutes Paris Edition de Sante, pp. 395-398.
22. Otsuka, M., Onone, M. and Matsuda, Y. (1996) J. Pharm. Sci., 82, pp. 32-38.
23. Torrado, Su., Torrado, Sa., Torrado, J. and Cadorniga, R. (1996) Int. J. Pharm., 140, pp. 247-259.
24. Leuner, C. and Dressman, J. (2000) Eur. J. of Pharm. and Biopharm., 50, pp. 47-60.
25. Mooter, G. Van den, Augustijns, P., Blaton, N. and Kinget, R. (1998) Int. J. Pharm., 164, pp. 67-80.
26. Susumu, H., Takeshi, H., Naho, F., Akira, K., Etsuo, Y. and Katsuhide, T. (2005) Int. J. Pharm., 302, pp. 103-112.
27. Teresa, M. M., Victoria, M. M. and Gloria, E. S. (2002) Il Farmaco., 57, pp. 723-727.
28. Franco, M., Trapani, G., Latrofa, A., Tullio, C., Provenzano, M. R., Serra, M., Muggironi, M., Biggio, G. and Liso, G. (2001) Int. J. Pharm., 225, pp. 63-73.
29. Melgardt, M. V., Dale, E. W., Jakkie, G. and Amol, K. (1998) Int. J. Pharm., 163, pp. 219-224.
30. Arias, M. J., Moyano, J. R. and Gines, J. M. (1998) Thermochimica Acta., 321, pp. 33-41.
31. Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J. and Springer, J. (1980) J. Proc Natl Acad Sci., 77, p. 3957.
32. Ellison, D. K., Moore, W. D., Petts, C. R. and Simvastatin (1992) Analytical Profiles of Drug Substances and Excipients, 22, pp. 359-388. Academic press, Inc, New York
33. Higuchi, T. and Connors, K. (1965) Advances in Analytical Chemistry and Instrumention, 4, pp. 17-123.
34. Frances, C., Veiga, M. D., Espanol, O. M. and Cadorniga, R. (1991) Int. J. Pharm., 77, pp. 193-198.
35. Christian, L. and Jennifer, D. (2000) Eur. J. of Pharm. and Biopharm., 50, pp. 47-60.
36. Moore, J. W. and Flanner, H. (1996) Pharm. Tech., 20, pp. 64-74.
37. Chengsheng, L. and Kashappa, H. D. (2005) Drug Dev. Ind. Pharm., 1, pp. 1-10.
38. Horter, D. and Dressman, J. B. (1997) Advanced Drug Delivery Reviews, 25, pp. 3-14.
39. Skelly, J. P., Van Buskirk, G. A., Savello, D. R., Amidon, G. L., Arbit, H. M., Dighe, S., Fawzi, M. B., Gonzalez, M. A., Malick, A. W., Malinowski, H., Nedich, R., Peck, G. E., Pearce, D. M., Shah, V., Shangraw, R. F., Schwartz, J. B. and Truelove, J. (1993) Pharm. Res., 10, pp. 313-316.
40. Galia, E., Horton, J. and Dressman, J. B. (1999) Pharm. Res., 16, pp. 1871-1875.
41. Noory, C., Tran, N., Ouderkirk, L., Brown, S., Perry, J., Lopez, J., Colon, M. and Faberlle, M. (1999) Dissolution Technologies, 6, pp. 6-7.
42. Shah, V. P., Noory, A., Noory, C., McCullough, B., Clarke, S., Everett, R., Naviasky, H., Srinivasan, B. N., Fortman, D. and Skelly, J. P. (1995) Int. J. Pharm., 125, pp. 99-106.
43. Barzegar-Jalali, M., Maleki, N., Garjani, A., Khandar, A. A., Haji-Hosseinloo, M., Jabbari, R. C. and Dasmalchi, S. (2002) Drug Dev. Ind. Pharm., 28, pp. 681-686.
44. Tang, L., Khan, S. U. and Muhmmad, N. A. (2001) Pharmaceutical Development Technology., 6, pp. 531-540.
45. Reppas, C. and Nicolaides, E. (2000) Oral Drug Absorption Prediction and Assessment, pp. 229-254. Marcel Dekker, Inc., New York
46. Vueba, M. L., de Carvalho, L. A.E. Batista, Veiga, F., Sousa, J. J. and Pina, M. E. (2004) Eur. J. of Pharm. and Biopharm., 58, pp. 51-59.
47. Aulton, M. E. (1988) Pharmaceutics: The Science of Dosage Form Design, pp. 600-616. Churchill Livingstone, London, UK